Drug Healthcare and Patient Safety

期刊简介：Drug, Healthcare and Patient Safety is an international, peer-reviewed, open-access journal exploring patient safety issues in the healthcare continuum from diagnostic and screening interventions through to treatment, drug therapy, and surgery. The journal is characterized by the rapid reporting of reviews, original research, clinical, epidemiological, and post-marketing surveillance studies, risk management, health literacy, and educational programs across all areas of healthcare safety. Also, guidelines on data requirements to assure acceptable safety levels in license applications, post-marketing protocols on monitoring safety, adverse reaction case reports, and managing associated morbidity and mortality are key topics. Drug utilization studies, intervention research, and policy research focusing on healthcare safety are also welcome. Balancing risk, effectiveness, patient satisfaction, quality of life, and the development and testing of new interventions to optimize safety outcomes in disease management are major areas of interest for the journal. Study protocols, animal and in vitro toxicity studies are out of scope for the journal. Drug, Healthcare and Patient Safety will no longer consider meta-analyses for publication.

【译文】《药物、医疗保健和患者安全》是一本国际同行评审、开放获取期刊，探讨从诊断和筛查干预到治疗、药物治疗和手术的医疗保健连续体中的患者安全问题。该杂志的特点是快速报告医疗安全所有领域的评论、原创研究、临床、流行病学和上市后监测研究、风险管理、健康素养和教育计划。此外，确保许可证申请中可接受的安全水平的数据要求指南、安全性监测的上市后协议、不良反应病例报告以及相关发病率和死亡率的管理也是关键主题。也欢迎以医疗安全为重点的药物利用研究、干预研究和政策研究。平衡风险、有效性、患者满意度、生活质量以及开发和测试新干预措施以优化疾病管理的安全结果是该杂志感兴趣的主要领域。研究方案、动物和体外毒性研究不属于该杂志的范围。药物、医疗保健和患者安全将不再考虑发表荟萃分析。